Glenn joined Notable Labs as chief medical officer in 2023.
He has been working in the pharmaceutical industry, specializing in oncology and clinical trials for over 25 years. He made his start with Agouron/Pfizer serving in roles with increasing responsibility from medical director to VP of clinical development at established biopharma companies such as Cell Therapeutics, Chiron, Sunesis, Portola, and Genentech, and was also chief medical officer at Plexxikon. Glenn founded Audentes Consulting in 2018 to share best practices and lessons learned from his experience in oncology clinical development with startups and smaller companies.
He completed a residency in Internal Medicine at the University of Pittsburgh and completed his Medical Oncology/Hematology fellowship at the University of Chicago.
Glenn received his bachelor’s in Chemistry, as well as his MD, from the University of Louisville.
